Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

elevance health inc. - ELV

ELV

Close Chg Chg %
430.12 -0.45 -0.10%

Closed Market

429.67

-0.45 (0.10%)

Volume: 779.12K

Last Updated:

Nov 13, 2026, 3:59 PM EDT

Trade Now

Company Overview: elevance health inc. - ELV

ELV Key Data

Open

$431.09

 Day Range

420.87 - 433.67

52 Week Range

274.84 - 450.69

 Market Cap

$92.79B

Shares Outstanding

216.06M

 Public Float

215.55M

Beta

0.63

 Rev. Per Employee

N/A

P/E Ratio

18.31

 EPS

$23.55

Yield

159.80%

 Dividend

$1.72

EX-DIVIDEND DATE

Dec 4, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.39M

  

ELV Performance

1 Week
 
 0.96%
 
1 Month
 
 0.33%
 
3 Months
 
 7.34%
 
1 Year
 
 31.88%
 
5 Years
 
 -1.68%
 

ELV Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 25
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 478.714
Number of Ratings 25 Current Quarters Estimate 2.081
FY Report Date 12 / 2026 Current Year's Estimate 29.051
Last Quarter’s Earnings 6.99 Median PE on CY Estimate N/A
Year Ago Earnings 30.29 Next Fiscal Year Estimate 30.248
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 22 16 23 22
Mean Estimate 2.08 12.41 29.05 30.25
High Estimates 3.22 13.67 30.28 31.75
Low Estimate 1.64 8.69 27.20 29.00
Coefficient of Variance 14.11 9.05 1.70 1.74

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 13
OVERWEIGHT 4 4 4
HOLD 9 9 8
UNDERWEIGHT 0 0 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Elevance Health Inc. - ELV

Date Name Shares Transaction Value
Nov 9, 2026 Ratnakar Lavu EVP & Chief Digital Info Ofr 14,849 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $440 per share 6,533,560.00
Oct 7, 2026 Mark B. Kaye EVP & CFO 27,876 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $386.43 per share 10,772,122.68
Oct 7, 2026 Mark B. Kaye EVP & CFO 30,503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Elevance Health Inc. in the News